Charles Schwab Investment Management Inc Tango Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 601,447 shares of TNGX stock, worth $5.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
601,447
Previous 548,014
9.75%
Holding current value
$5.45 Million
Previous $750,000
310.53%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
117MCall Options Held
245KPut Options Held
19.5K-
Trv Gp Iv, LLC Boston, MA16.9MShares$153 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$97.3 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$96.3 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$83 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$54.6 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $798M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...